Dr. Wong provides clinical thought leadership and strategy for AccessHope, a digital health company delivering remote expert oncology opinions to approximately 10 million members across more than 700 employers and health plans, including over 70 “Fortune 500” companies. A triple board-certified physician in medical oncology, hospice and palliative medicine and internal medicine, Dr. Wong led and presented a population-based study at the 2025 American Society of Clinical Oncology Quality Care Symposium, peer-reviewed and published in the JCO Oncology Practice, analyzing 5,137 expert case reviews and demonstrating that the platform recommended changes in cancer treatment in 52% of cases, with patients in socioeconomically disadvantaged and non-urban areas showing 25% higher odds of receiving treatment recommendations. She shapes how AccessHope’s physician- and patient-facing technology platforms are developed, deployed and optimized, defines the clinically meaningful metrics that anchor the platform and leads initiatives to reduce administrative burden for both AccessHope’s physician reviewers and the local treating oncologists who receive expert opinions. AccessHope was awarded “Best Virtual Care Solution Provider” in the MedTech Breakthrough Awards program in 2025.
